Ewing's Tumor Recurrent
4 clinical trials · Condition
◉ Watch Ewing's Tumor Recurrent
| Record | Firm | Date |
|---|---|---|
| A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide (NCT03495921) | Gradalis, Inc. | 2018-08-21 |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma (NCT02982486) | Assaf-Harofeh Medical Center | 2017-12-01 |
| Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma (NCT02736565) | Gradalis, Inc. | 2016-10-01 |
Track Ewing's Tumor Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.